The Medical CBRN Defense Consortium (MCDC) has presented a Prototype Innovation Award to Kaléo for the development of the Rapid Opioid Countermeasure System (ROCS), a 10 mg naloxone hydrochloride auto-injector [...] Read the full story at CBRNE Central: Kaléo Receives Inaugural MCDC Innovation Award for High-Potency Opioid Countermeasure.| CBRNE Central
ARPA-H’s FRONT program may pave the way to meaningful recovery after traumatic brain injury (TBI) caused by blast exposure.| CBRNE Central